Dysregulation of miR-3607 predicts prognosis of hepatocellular carcinoma and regulates tumor cell proliferation, migration and invasion
Authors:
Open Access
- 13 May 2020
- journal article
- research article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 15 (1) , 1-9
Abstract
Background: Hepatocellular carcinoma (HCC) is one of the most common global malignancies with increasing morbidity and mortality. The purpose of this study was to investigate the expression levels and prognostic value of microRNA-3607 (miR-3607) in patients with HCC. Methods: The expression of miR-3607 was estimated by quantitative real-time RT-PCR. Survival analysis using the Kaplan-Meier method and Cox regression analysis was conducted to evaluate the prognostic value of miR-3607. The functional role of miR-3607 in HCC progression was further assessed using gain- and loss-of-function experiments. Bioinformatics analysis and a dual-luciferase reporter assay were used to explore the direct targets of miR-3607. Results: miR-3607 expression was found to be significantly decreased in HCC tissues and cells compared with the matched tissues and cells (P < 0.001). The decreased expression of miR-3607 was associated with the patients’ tumor size and TNM stage (all P < 0.05). According to the survival curves, patients with low miR-3607 expression had poorer overall survival than those with high levels (log-rank P = 0.012). Moreover, the Cox analysis results indicated that miR-3607 expression was an independent prognostic factor for HCC. The results of cell experiments revealed that the overexpression of miR-3607 in HCC cells led to the inhibited cell proliferation, migration, and invasion. TGFBR1 was identified as a direct target of miR-3607. Conclusion: The data of this study indicated that the decreased expression of miR-3607 in HCC predicts poor prognosis and the overexpression of miR-3607 in HCC cells can suppress the tumor progression by targeting TGFBR1. This study provides a novel insight into the prognosis and treatment of HCC, and miR-3607 serves as a candidate prognostic biomarker and therapeutic target of HCC.Keywords
Funding Information
- Shandong Medicine and Health Science Technology Development Project (No. 2017WS849; No. 2017WS777)
This publication has 38 references indexed in Scilit:
- Regulation of SRC Kinases by microRNA-3607 Located in a Frequently Deleted Locus in Prostate CancerMolecular Cancer Therapeutics, 2014
- Hepatocellular carcinoma: clinical frontiers and perspectivesGut, 2014
- miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinomaJournal of Cancer Research and Clinical Oncology, 2014
- Novel expression profiles of microRNAs suggest that specific miRNAs regulate gene expression for the sexual maturation of female Schistosoma japonicum after pairingParasites & Vectors, 2014
- miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell ProgressionClinical Cancer Research, 2013
- Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosisJournal of Surgical Oncology, 2013
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3Molecular Cancer Research, 2011
- hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma TherapyCancer Research, 2010
- Proteomics for the early detection and treatment of hepatocellular carcinomaOncogene, 2006